Literature DB >> 25674202

Role of caveolae in high glucose and TGF-β₁ induced fibronectin production in rat mesangial cells.

Yuantao Liu1, Shengxia Lu2, Yuchao Zhang3, Xiangdong Wang3, Feng Kong4, Ye Liu5, Li Peng1, Yuqin Fu5.   

Abstract

Accumulation of extracellular matrix (ECM) in glomerular mesangium correlates with loss of renal function in diabetic nephropathy. However, the mechanisms underlying are still incompletely known. In the present study, we explored the role of caveolae in ECM production in rat mesangial cells (MCs) stimulated by high glucose or transforming growth factor-β1 (TGF-β1), and investigated the possible mechanisms. High glucose (HG) or TGF-β1 significantly increased collagen-1 and fibronectin expression at both mRNA and protein levels in time- course dependent manners, and simultaneously induced caveolin-1 tyrosine phosphorylation. Disruption of caveolae with Methyl-β-cyclodextrin (β-MCD) prevented HG and TGF-β1 induced caveolin-1 tyrosine phosphorylation, and attenuated fibronectin but not collagen-1 production. This effect of β-MCD on fibronectin production could be abolished by cholesterol, which restored HG and TGF-β1 induced caveolin-1 tyrosine phosphorylation. In addition, HG and TGF-β1 induced fibronectin production was attenuated by a caveolin-1 scaffold domain peptide. These findings indicate that mesangial cell caveolae regulate fibronectin production at least partly through caveolin-1 phosphorylation.

Entities:  

Keywords:  Caveolae; TGF-β1; fibronectin; high glucose; mesangial cells

Mesh:

Substances:

Year:  2014        PMID: 25674202      PMCID: PMC4314031     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  29 in total

1.  A phosphotyrosine-dependent protein interaction screen reveals a role for phosphorylation of caveolin-1 on tyrosine 14: recruitment of C-terminal Src kinase.

Authors:  Haiming Cao; William E Courchesne; Cynthia Corley Mastick
Journal:  J Biol Chem       Date:  2002-01-22       Impact factor: 5.157

Review 2.  Caveolins and caveolae: molecular and functional relationships.

Authors:  B Razani; M P Lisanti
Journal:  Exp Cell Res       Date:  2001-11-15       Impact factor: 3.905

Review 3.  Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy.

Authors:  M E Cooper
Journal:  Diabetologia       Date:  2001-11       Impact factor: 10.122

4.  Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor.

Authors:  B Razani; X L Zhang; M Bitzer; G von Gersdorff; E P Böttinger; M P Lisanti
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

Review 5.  Extracellular matrix metabolism in diabetic nephropathy.

Authors:  Roger M Mason; Nadia Abdel Wahab
Journal:  J Am Soc Nephrol       Date:  2003-05       Impact factor: 10.121

6.  Caveolae in mesangial cells and caveolin expression in mesangial proliferative glomerulonephritis.

Authors:  O Tamai; N Oka; T Kikuchi; Y Koda; M Soejima; Y Wada; M Fujisawa; K Tamaki; H Kawachi; F Shimizu; H Kimura; T Imaizumi; S Okuda
Journal:  Kidney Int       Date:  2001-02       Impact factor: 10.612

7.  Epidermal growth factor-stimulated tyrosine phosphorylation of caveolin-1. Enhanced caveolin-1 tyrosine phosphorylation following aberrant epidermal growth factor receptor status.

Authors:  Y N Kim; G J Wiepz; A G Guadarrama; P J Bertics
Journal:  J Biol Chem       Date:  2000-03-17       Impact factor: 5.157

Review 8.  TGF-beta signal transduction and mesangial cell fibrogenesis.

Authors:  H William Schnaper; Tomoko Hayashida; Susan C Hubchak; Anne-Christine Poncelet
Journal:  Am J Physiol Renal Physiol       Date:  2003-02

9.  Redox-induced Src kinase and caveolin-1 signaling in TGF-β1-initiated SMAD2/3 activation and PAI-1 expression.

Authors:  Rohan Samarakoon; Subhanir S Chitnis; Stephen P Higgins; Craig E Higgins; Joan C Krepinsky; Paul J Higgins
Journal:  PLoS One       Date:  2011-07-28       Impact factor: 3.240

Review 10.  Interstitial fibrosis and growth factors.

Authors:  J A Lasky; A R Brody
Journal:  Environ Health Perspect       Date:  2000-08       Impact factor: 9.031

View more
  6 in total

Review 1.  Caveolin-1 in the Pathogenesis of Diabetic Nephropathy: Potential Therapeutic Target?

Authors:  Richard Van Krieken; Joan C Krepinsky
Journal:  Curr Diab Rep       Date:  2017-03       Impact factor: 4.810

2.  Glomerulopathic Light Chain-Mesangial Cell Interactions: Sortilin-Related Receptor (SORL1) and Signaling.

Authors:  Guillermo A Herrera; Luis Del Pozo-Yauner; Jiamin Teng; Chun Zeng; Xinggui Shen; Takahito Moriyama; Veronica Ramirez Alcantara; Bing Liu; Elba A Turbat-Herrera
Journal:  Kidney Int Rep       Date:  2021-03-13

3.  Influence of high glucose on mesangial cell-derived exosome composition, secretion and cell communication.

Authors:  Antônio da Silva Novaes; Fernanda Teixeira Borges; Edgar Maquigussa; Vanessa Araújo Varela; Marcos Vinicios Salles Dias; Mirian Aparecida Boim
Journal:  Sci Rep       Date:  2019-04-18       Impact factor: 4.379

4.  Mangosteen peel extract (Garcinia mangostana L.) as protective agent in glucose-induced mesangial cell as in vitro model of diabetic glomerulosclerosis.

Authors:  Wahyu Widowati; Dian Ratih Laksmitawati; Teresa Liliana Wargasetia; Ervi Afifah; Annisa Amalia; Yukko Arinta; Rizal Rizal; Tri Suciati
Journal:  Iran J Basic Med Sci       Date:  2018-09       Impact factor: 2.699

5.  Nutrition profile and potency of RGD motif in protein hydrolysate of green peas as an antifibrosis in chronic kidney disease.

Authors:  Meilinah Hidayat; Sijani Prahastuti; Muhammad Yusuf; Khomaini Hasan
Journal:  Iran J Basic Med Sci       Date:  2021-06       Impact factor: 2.699

6.  miR-486-5p Restrains Extracellular Matrix Production and Oxidative Damage in Human Trabecular Meshwork Cells by Targeting TGF-β/SMAD2 Pathway.

Authors:  Le Xu; Yiming Zhang; Hua Long; Bo Zhou; Haibo Jiang
Journal:  J Ophthalmol       Date:  2022-02-23       Impact factor: 1.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.